Biovail’s Ralivia receives approvable letter
Biovail has received an approvable letter from the FDA for the drug, but it has yet to be approved.
The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.
Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.
Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.